All terms in EFO
| Label | Id | Description |
|---|---|---|
| partial deletion of the long arm of chromosome 11 | MONDO_0016910 | [A cytogenetic abnormality that refers to the allelic loss of all or part of the long arm of chromosome 11.] |
| platelet-type bleeding disorder 17 | MONDO_0008553 | [An autosomal dominant condition caused by mutation(s) in the GFI1B gene, encoding zinc finger protein Gfi-1b. It is characterized by a tendency for increased bleeding due to abnormal platelet function.] |
| thoracolaryngopelvic dysplasia | MONDO_0008551 | [A short-rib dysplasia characterized by thoracic dystrophy, laryngeal stenosis and a small pelvis.] |
| respiratory malformation | MONDO_0015930 | |
| short rib dysplasia | MONDO_0019691 | |
| thrombophilia due to activated protein C resistance | MONDO_0008560 | [A hemostatic disorder characterized by a poor anticoagulant response to activated protein C (APC). The activated form of Factor V (Factor Va) is more slowly degraded by activated protein C. Factor V Leiden mutation (R506Q) is the most common cause of APC resistance.] |
| hamartoma of skin appendage | MONDO_0021539 | [A hamartoma (disease) that involves the cutaneous appendage.] |
| epidermal appendage tumor | MONDO_0002297 | [A benign or malignant neoplasm that arises from the hair follicles, sebaceous glands, or sweat glands.] |
| myomatous neoplasm | MONDO_0021545 | [A benign or malignant mesenchymal neoplasm arising from smooth, skeletal, or cardiac muscle.] |
| muscle tissue disorder | MONDO_0003939 | [A disease involving the muscle tissue.] |
| mesenchymal cell neoplasm | MONDO_0002616 | [A benign, intermediate, or malignant neoplasm that arises from the mesenchyma-derived cells of the soft tissue or bone. Representative examples include lipoma, leiomyoma, leiomyosarcoma and osteosarcoma.] |
| Bartholin Gland Squamous Cell Carcinoma | EFO_1000104 | [A carcinoma that arises from the Bartholin gland and is characterized by the presence of malignant squamous epithelial cells.] |
| Bartholin Gland Carcinoma | EFO_1000103 | [A carcinoma that arises from the Bartholin gland. It usually affects women over fifty and presents with enlargement of the Bartholin gland. Various histologic subtypes have been identified and include adenocarcinoma, squamous cell carcinoma, adenoid cystic carcinoma, adenosquamous carcinoma, transitional cell carcinoma, and small cell carcinoma.] |
| Basaloid Carcinoma | EFO_1000105 | [A malignant epithelial neoplasm characterized by the presence of neoplastic cells with hyperchromatic nuclei, small amount of cytoplasm, and peripheral nuclear palisading.] |
| B-Cell Prolymphocytic Leukemia | EFO_1000102 | [A neoplasm of prolymphocytes affecting the blood, bone marrow, and spleen. It is characterized by prolymphocytes exceeding 55% of the lymphoid cells in the blood and profound splenomegaly.] |
| neoplasm of mature B-cells | EFO_0000096 | [A neoplasm of follicle centre B cells which has at least a partial follicular pattern. Follicular lymphomas comprise about 35% of adult non-Hodgkin lymphomas in the U.S. and 22% worldwide. Most patients have widespread disease at diagnosis. Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present. The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)]. Histological grade correlates with prognosis. Grades 1 and 2 follicular lymphomas are indolent and grade 3 is more aggressive (adapted from WHO, 2001).] |
| aggressive B-cell non-Hodgkin lymphoma | MONDO_0017595 | |
| familial thyroglossal duct cyst | MONDO_0008565 | [Familial thyroglossal duct cyst (TDC) is a very rare inherited form of TDC characterized by a mass measuring 3 cm in diameter or less in the midline area of the neck.] |
| cysts and fistulae of the face and oral cavity | MONDO_0015476 | |
| integumentary system cancer | MONDO_0000653 | [A malignant neoplasm involving the integumental system] |